These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34914540)

  • 1. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
    Joyce MG; King HAD; Elakhal-Naouar I; Ahmed A; Peachman KK; Macedo Cincotta C; Subra C; Chen RE; Thomas PV; Chen WH; Sankhala RS; Hajduczki A; Martinez EJ; Peterson CE; Chang WC; Choe M; Smith C; Lee PJ; Headley JA; Taddese MG; Elyard HA; Cook A; Anderson A; McGuckin Wuertz K; Dong M; Swafford I; Case JB; Currier JR; Lal KG; Molnar S; Nair MS; Dussupt V; Daye SP; Zeng X; Barkei EK; Staples HM; Alfson K; Carrion R; Krebs SJ; Paquin-Proulx D; Karasavva N; Polonis VR; Jagodzinski LL; Amare MF; Vasan S; Scott PT; Huang Y; Ho DD; de Val N; Diamond MS; Lewis MG; Rao M; Matyas GR; Gromowski GD; Peel SA; Michael NL; Bolton DL; Modjarrad K
    Sci Transl Med; 2022 Feb; 14(632):eabi5735. PubMed ID: 34914540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates.
    Joyce MG; King HAD; Naouar IE; Ahmed A; Peachman KK; Cincotta CM; Subra C; Chen RE; Thomas PV; Chen WH; Sankhala RS; Hajduczki A; Martinez EJ; Peterson CE; Chang WC; Choe M; Smith C; Lee PJ; Headley JA; Taddese MG; Elyard HA; Cook A; Anderson A; McGuckin-Wuertz K; Dong M; Swafford I; Case JB; Currier JR; Lal KG; O'Connell RJ; Molnar S; Nair MS; Dussupt V; Daye SP; Zeng X; Barkei EK; Staples HM; Alfson K; Carrion R; Krebs SJ; Paquin-Proulx D; Karasavva N; Polonis VR; Jagodzinski LL; Amare MF; Vasan S; Scott PT; Huang Y; Ho DD; de Val N; Diamond MS; Lewis MG; Rao M; Matyas GR; Gromowski GD; Peel SA; Michael NL; Bolton DL; Modjarrad K
    bioRxiv; 2021 Mar; ():. PubMed ID: 33791694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
    Sankhala RS; Lal KG; Jensen JL; Dussupt V; Mendez-Rivera L; Bai H; Wieczorek L; Mayer SV; Zemil M; Wagner DA; Townsley SM; Hajduczki A; Chang WC; Chen WH; Donofrio GC; Jian N; King HAD; Lorang CG; Martinez EJ; Rees PA; Peterson CE; Schmidt F; Hart TJ; Duso DK; Kummer LW; Casey SP; Williams JK; Kannan S; Slike BM; Smith L; Swafford I; Thomas PV; Tran U; Currier JR; Bolton DL; Davidson E; Doranz BJ; Hatziioannou T; Bieniasz PD; Paquin-Proulx D; Reiley WW; Rolland M; Sullivan NJ; Vasan S; Collins ND; Modjarrad K; Gromowski GD; Polonis VR; Michael NL; Krebs SJ; Joyce MG
    Nat Commun; 2024 Jan; 15(1):200. PubMed ID: 38172512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
    Corbett KS; Flynn B; Foulds KE; Francica JR; Boyoglu-Barnum S; Werner AP; Flach B; O'Connell S; Bock KW; Minai M; Nagata BM; Andersen H; Martinez DR; Noe AT; Douek N; Donaldson MM; Nji NN; Alvarado GS; Edwards DK; Flebbe DR; Lamb E; Doria-Rose NA; Lin BC; Louder MK; O'Dell S; Schmidt SD; Phung E; Chang LA; Yap C; Todd JM; Pessaint L; Van Ry A; Browne S; Greenhouse J; Putman-Taylor T; Strasbaugh A; Campbell TA; Cook A; Dodson A; Steingrebe K; Shi W; Zhang Y; Abiona OM; Wang L; Pegu A; Yang ES; Leung K; Zhou T; Teng IT; Widge A; Gordon I; Novik L; Gillespie RA; Loomis RJ; Moliva JI; Stewart-Jones G; Himansu S; Kong WP; Nason MC; Morabito KM; Ruckwardt TJ; Ledgerwood JE; Gaudinski MR; Kwong PD; Mascola JR; Carfi A; Lewis MG; Baric RS; McDermott A; Moore IN; Sullivan NJ; Roederer M; Seder RA; Graham BS
    N Engl J Med; 2020 Oct; 383(16):1544-1555. PubMed ID: 32722908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
    Pillet S; Arunachalam PS; Andreani G; Golden N; Fontenot J; Aye PP; Röltgen K; Lehmicke G; Gobeil P; Dubé C; Trépanier S; Charland N; D'Aoust MA; Russell-Lodrigue K; Monjure C; Blair RV; Boyd SD; Bohm RP; Rappaport J; Villinger F; Landry N; Pulendran B; Ward BJ
    Cell Mol Immunol; 2022 Feb; 19(2):222-233. PubMed ID: 34983950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.
    Francica JR; Flynn BJ; Foulds KE; Noe AT; Werner AP; Moore IN; Gagne M; Johnston TS; Tucker C; Davis RL; Flach B; O'Connell S; Andrew SF; Lamb E; Flebbe DR; Nurmukhambetova ST; Donaldson MM; Todd JM; Zhu AL; Atyeo C; Fischinger S; Gorman MJ; Shin S; Edara VV; Floyd K; Lai L; Boyoglu-Barnum S; Van De Wetering R; Tylor A; McCarthy E; Lecouturier V; Ruiz S; Berry C; Tibbitts T; Andersen H; Cook A; Dodson A; Pessaint L; Van Ry A; Koutsoukos M; Gutzeit C; Teng IT; Zhou T; Li D; Haynes BF; Kwong PD; McDermott A; Lewis MG; Fu TM; Chicz R; van der Most R; Corbett KS; Suthar MS; Alter G; Roederer M; Sullivan NJ; Douek DC; Graham BS; Casimiro D; Seder RA
    Sci Transl Med; 2021 Aug; 13(607):. PubMed ID: 34315825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    King HAD; Joyce MG; Lakhal-Naouar I; Ahmed A; Cincotta CM; Subra C; Peachman KK; Hack HR; Chen RE; Thomas PV; Chen WH; Sankhala RS; Hajduczki A; Martinez EJ; Peterson CE; Chang WC; Choe M; Smith C; Headley JA; Elyard HA; Cook A; Anderson A; Wuertz KM; Dong M; Swafford I; Case JB; Currier JR; Lal KG; Amare MF; Dussupt V; Molnar S; Daye SP; Zeng X; Barkei EK; Alfson K; Staples HM; Carrion R; Krebs SJ; Paquin-Proulx D; Karasavvas N; Polonis VR; Jagodzinski LL; Vasan S; Scott PT; Huang Y; Nair MS; Ho DD; de Val N; Diamond MS; Lewis MG; Rao M; Matyas GR; Gromowski GD; Peel SA; Michael NL; Modjarrad K; Bolton DL
    Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34470866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques.
    Yu J; Thomas PV; Sciacca M; Wu C; Liu J; He X; Miller J; Hachmann NP; Surve N; McMahan K; Jacob-Dolan C; Powers O; Hall K; Barrett J; Hope D; Mazurek CR; Murdza T; Chang WC; Golub E; Rees PA; Peterson CE; Hajduczki A; Chen WH; Martinez EJ; Hussin E; Lange C; Gong H; Matyas GR; Rao M; Suthar M; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Bolton DL; Michael NL; Joyce MG; Modjarrad K; Barouch DH
    Cell Rep Med; 2023 Apr; 4(4):101018. PubMed ID: 37023746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    Sun C; Yuan RY; Xie C; Sun JF; Fang XY; Hu YS; Yu XH; Liu Z; Zeng MS; Kang YF
    J Virol; 2022 Jul; 96(13):e0038322. PubMed ID: 35699445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
    Yu J; Thomas PV; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Martinez EJ; Chen WH; Sciacca M; Hachmann NP; Lifton M; Miller J; Powers OC; Hall K; Wu C; Barrett J; Swafford I; Currier JR; King J; Corbitt C; Chang WC; Golub E; Rees PA; Peterson CE; Hajduczki A; Hussin E; Lange C; Gong H; Matyas GR; Rao M; Paquin-Proulx D; Gromowski GD; Lewis MG; Andersen H; Davis-Gardner M; Suthar MS; Michael NL; Bolton DL; Joyce MG; Modjarrad K; Barouch DH
    Sci Adv; 2022 Nov; 8(47):eade4433. PubMed ID: 36417525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys.
    Li H; Guo L; Zheng H; Li J; Zhao X; Li J; Liang Y; Yang F; Zhao Y; Yang J; Xue M; Zuo Y; Zhou J; Chen Y; Yang Z; Li Y; Jin W; Shi H; He Z; Li Q; Liu L
    Bioconjug Chem; 2021 May; 32(5):1034-1046. PubMed ID: 33951913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers.
    Khan MS; Kim E; Le Hingrat Q; Kleinman A; Ferrari A; Sammartino JC; Percivalle E; Xu C; Huang S; Kenniston TW; Cassaniti I; Baldanti F; Pandrea I; Gambotto A; Apetrei C
    mBio; 2023 Oct; 14(5):e0207023. PubMed ID: 37830800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs.
    Liu Z; Zhou J; Xu W; Deng W; Wang Y; Wang M; Wang Q; Hsieh M; Dong J; Wang X; Huang W; Xing L; He M; Tao C; Xie Y; Zhang Y; Wang Y; Zhao J; Yuan Z; Qin C; Jiang S; Lu L
    Cell Res; 2022 Mar; 32(3):269-287. PubMed ID: 35046518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    King HAD; Gordon Joyce M; Naouar IE; Ahmed A; Cincotta CM; Subra C; Peachman KK; Hack HH; Chen RE; Thomas PV; Chen WH; Sankhala RS; Hajduczki A; Martinez EJ; Peterson CE; Chang WC; Choe M; Smith C; Headley JA; Elyard HA; Cook A; Anderson A; Wuertz KM; Dong M; Swafford I; Case JB; Currier JR; Lal KG; Amare MF; Dussupt V; Molnar S; Daye SP; Zeng X; Barkei EK; Alfson K; Staples HM; Carrion R; Krebs SJ; Paquin-Proulx D; Karasavvas N; Polonis VR; Jagodzinski LL; Vasan S; Scott PT; Huang Y; Nair MS; Ho DD; de Val N; Diamond MS; Lewis MG; Rao M; Matyas GR; Gromowski GD; Peel SA; Michael NL; Modjarrad K; Bolton DL
    bioRxiv; 2021 Apr; ():. PubMed ID: 33851155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates.
    Zamani P; Mashreghi M; Rezazade Bazaz M; Zargari S; Alizadeh F; Dorrigiv M; Abdoli A; Aminianfar H; Hatamipour M; Zarqi J; Behboodifar S; Samsami Y; Khorshid Sokhangouy S; Sefidbakht Y; Uskoković V; Rezayat SM; Jaafari MR; Mozaffari-Jovin S
    J Control Release; 2023 Aug; 360():316-334. PubMed ID: 37355212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models.
    Zhang Y; Sun J; Zheng J; Li S; Rao H; Dai J; Zhang Z; Wang Y; Liu D; Chen Z; Ran W; Zhu A; Li F; Yan Q; Wang Y; Yu K; Zhang S; Wang D; Tang Y; Liu B; Cheng L; Huo J; Perlman S; Zhao J; Zhao J
    Adv Sci (Weinh); 2024 Mar; 11(9):e2303366. PubMed ID: 38105421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.
    Rappaport AR; Hong SJ; Scallan CD; Gitlin L; Akoopie A; Boucher GR; Egorova M; Espinosa JA; Fidanza M; Kachura MA; Shen A; Sivko G; Van Abbema A; Veres RL; Jooss K
    Nat Commun; 2022 Jun; 13(1):3289. PubMed ID: 35672369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.